Clinical Trial

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Study acronym: ERASE-GC
Recruiting
View on ClinicalTrials.gov →
Summary
This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-15; most recent amendment 2024-12-25.
Status change: Not Yet Recruiting → Recruiting 2021-09-02
Trial Details
NCT Number NCT04890171
Lead Sponsor National Cancer Center, Korea
Collaborators: Seoul St. Mary's Hospital, Chilgok Kyungpook National University Hospital, Pusan National University Hospital, Samsung Medical Center, Severance Hospital, Yonsei University College of Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Asan Medical Center, Chonnam National University Hospital
Conditions Stomach Cancer, Undifferentiated Type, Expanded Indication of Endoscopic Resection
Enrollment 708 participants
Start Date 2021-06-11
Primary Completion 2028-02-28 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-12-27